Bellicum Pharma (BLCM) Misses Q4 EPS by 19c

Bellicum Pharma (NASDAQ: BLCM) reported Q4 EPS of ($0.63), $0.19 worse than the analyst estimate of ($0.44).

For earnings history and earnings-related data on Bellicum Pharma (BLCM) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15